🇺🇸 FDA
Company

Dogwood

Dogwood Therapeutics

DWTX pharma USA

Quick answer

Dogwood is a pharma company (DWTX) headquartered in ALPHARETTA, GA, USA with 1 tracked pipeline programs.

Pipeline (1)

project

Halneuron

Chemotherapy Induced Neuropathic Pain

Phase 2 · small_molecule · active

1 trials

Patents (7)

patent

US 9446021

Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and

Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9120754

Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and

Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8349848

Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine recept

Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8293720

Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl

Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8263762

Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2A

Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8258142

Substituted 8-[6-amino-3-pyridyl]xanthines

Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8252767

Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl

Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)